Q-linea AB (publ) announced the first shipment of an IVD-marked instrument to the US for evaluation at customer site. Following the FDA approval of ASTar on April 26, 2024, Q-linea has now begun to ship instruments ready-built for the US market with dedicated software and consumables. The first such instrument has been sent from Uppsala bound for installation at a customer site.

Evaluations of the instrument are scheduled to take place over the next several months.